{
  "metadata": {
    "case_id": 23,
    "model": "Gemini-3-Pro",
    "timestamp": "2025-11-29T15:20:45.596264",
    "total_alignments": 4,
    "target_section": "protocolSection",
    "ground_truth_path": "/{YOURPATH}/samples/CTG/protocolSection/1_100/23_NCT02487654.json",
    "prediction_path": "/{YOURPATH}/restructured_outputs_protocol/Gemini-3-Pro/23_Gemini-3-Pro.json",
    "shard_range": "1_100"
  },
  "alignments": [
    {
      "field_path": "protocolSection.armsInterventionsModule.armGroups",
      "algorithm": "hungarian",
      "ref_count": 2,
      "pred_count": 2,
      "similarity_matrix": [
        [
          0.4,
          0.96
        ],
        [
          0.94,
          0.4
        ]
      ],
      "matched_pairs": [
        {
          "ref_idx": 0,
          "pred_idx": 1,
          "score": 0.96,
          "status": "matched",
          "ref_item": {
            "label": "Pulmonary vein isolation",
            "type": "ACTIVE_COMPARATOR",
            "description": "Conventional endocardial radiofrequency catheter ablation for pulmonary vein isolation.",
            "interventionNames": [
              "Procedure: Pulmonary vein isolation"
            ]
          },
          "pred_item": {
            "label": "Pulmonary Vein Isolation (PVI)",
            "type": "ACTIVE_COMPARATOR",
            "description": "Patients randomized to this arm underwent standard pulmonary vein isolation using wide antral circumferential ablation around the pulmonary veins.",
            "interventionNames": [
              "Pulmonary Vein Isolation (PVI)"
            ]
          }
        },
        {
          "ref_idx": 1,
          "pred_idx": 0,
          "score": 0.94,
          "status": "matched",
          "ref_item": {
            "label": "Ganglionated plexus ablation",
            "type": "EXPERIMENTAL",
            "description": "Endocardial radiofrequency catheter ablation of ganglionated plexus in the left atrium",
            "interventionNames": [
              "Procedure: Ganglionated plexus ablation"
            ]
          },
          "pred_item": {
            "label": "Ganglionated Plexus Ablation (GPA)",
            "type": "EXPERIMENTAL",
            "description": "Patients randomized to this arm underwent mapping and ablation of ectopy-triggering ganglionated plexuses (ET-GPs) without pulmonary vein isolation (PVI). If triggered AF became incessant, atrioventricular dissociating GPs were also ablated.",
            "interventionNames": [
              "Ganglionated Plexus Ablation (GPA)"
            ]
          }
        }
      ]
    },
    {
      "field_path": "protocolSection.armsInterventionsModule.interventions",
      "algorithm": "hungarian",
      "ref_count": 2,
      "pred_count": 2,
      "similarity_matrix": [
        [
          0.4,
          0.98
        ],
        [
          0.93,
          0.6
        ]
      ],
      "matched_pairs": [
        {
          "ref_idx": 0,
          "pred_idx": 1,
          "score": 0.98,
          "status": "matched",
          "ref_item": {
            "type": "PROCEDURE",
            "name": "Pulmonary vein isolation",
            "description": "Conventional endocardial radiofrequency catheter ablation for pulmonary vein isolation.",
            "armGroupLabels": [
              "Pulmonary vein isolation"
            ],
            "otherNames": [
              "PVI"
            ]
          },
          "pred_item": {
            "type": "PROCEDURE",
            "name": "Pulmonary Vein Isolation (PVI)",
            "description": "Wide antral circumferential ablation performed around the pulmonary veins using contiguous point-by-point radiofrequency ablation lesions to achieve electrical isolation (entry and exit block).",
            "armGroupLabels": [
              "Pulmonary Vein Isolation (PVI)"
            ]
          }
        },
        {
          "ref_idx": 1,
          "pred_idx": 0,
          "score": 0.93,
          "status": "matched",
          "ref_item": {
            "type": "PROCEDURE",
            "name": "Ganglionated plexus ablation",
            "description": "Endocardial radiofrequency catheter ablation of ganglionated plexus in the left atrium",
            "armGroupLabels": [
              "Ganglionated plexus ablation"
            ],
            "otherNames": [
              "GP ablation"
            ]
          },
          "pred_item": {
            "type": "PROCEDURE",
            "name": "Ganglionated Plexus Ablation (GPA)",
            "description": "High frequency stimulation (HFS) was used to map GPs. ET-GPs were ablated using radiofrequency energy until nonfunctional. If incessant AF occurred, AVD-GPs were also targeted. This was performed without PVI.",
            "armGroupLabels": [
              "Ganglionated Plexus Ablation (GPA)"
            ]
          }
        }
      ]
    },
    {
      "field_path": "protocolSection.outcomesModule.primaryOutcomes",
      "algorithm": "hungarian",
      "ref_count": 1,
      "pred_count": 1,
      "similarity_matrix": [
        [
          0.95
        ]
      ],
      "matched_pairs": [
        {
          "ref_idx": 0,
          "pred_idx": 0,
          "score": 0.95,
          "status": "matched",
          "ref_item": {
            "measure": "Number of Patients With no Evidence of >30s Recurrent Atrial Arrhythmia Post-index Procedure",
            "description": "That is documented recurrent atrial arrhythmia lasting 30 seconds or more after a blanking period of 3 months; the outcome measure will be assessed up to 12 months of follow-up with 48hr halter monitors arranged every 3 months to investigate Arrhythmia recurrence .",
            "timeFrame": "3 to 12 months post-ablation."
          },
          "pred_item": {
            "measure": "Atrial arrhythmia recurrence",
            "description": "Any documented atrial arrhythmia (atrial fibrillation, atrial tachycardia, or atrial flutter) lasting for â‰¥30 seconds consecutively recorded on the Holter monitor, 12-lead ECG, pacemaker, loop recorder, and AliveCor Kardia recorded ECG.",
            "timeFrame": "At 12 months (after a 90-day blanking period)"
          }
        }
      ]
    },
    {
      "field_path": "protocolSection.outcomesModule.secondaryOutcomes",
      "algorithm": "hungarian",
      "ref_count": 1,
      "pred_count": 4,
      "similarity_matrix": [
        [
          0.3,
          0.25,
          0.1,
          0.93
        ]
      ],
      "matched_pairs": [
        {
          "ref_idx": 0,
          "pred_idx": 3,
          "score": 0.93,
          "status": "matched",
          "ref_item": {
            "measure": "Number of Participants Presenting a Reduction in the Usage of Antiarrhythmics Post-ablation",
            "description": "The reduction was defined as either a decrease of dose or a cessation of a drug over a 12 month follow-up period post ablation.",
            "timeFrame": "3 to 12 months post-ablation."
          },
          "pred_item": {
            "measure": "Antiarrhythmic drug usage",
            "description": "Reduction in the usage of antiarrhythmic drugs (AADs) postablation compared to baseline.",
            "timeFrame": "12 months"
          }
        }
      ]
    }
  ]
}